the aid library

LIST OPTIONS

Filter

1906

Sort by:

Direction:

Download (485)

View PDF (991)

Ghana 2014 Status Report for the National HIV and AIDS Response

Ghana AIDS Commission (2014) C1

Download (225)

View PDF (173)

Thematic segment: Mental Health and HIV/AIDS – Promoting human rights, an integrated and person-centered approach to improving art adherence, well-being and quality of life

UNAIDS; STRIVE (2018) C2

1-13 December 2018 | Geneva, Switzerland UNAIDS Programme Coordinating Board Issue date: 23 November 2018 UNAIDS/PCB (43)/18.32

Download (86)

View PDF (136)

Translating Community Research Into Global Policy Reform For National Action

S. Dilmitis; A. Welbourn; F. Anam; et al. ICW Latina; ICW WA; UNAIDS; et al. (2018) C2

Translating Community Research Into Global Policy Reform For National Action: A Checklist For Community Engagement To Implement The WHO Consolidated Guideline On The Sexual And Reproductive Health And Rights Of Women Living With HIV 3rd edition | December 2018

Download (267)

View PDF (522)

Living Conditions among People with Activity Limitations in Malawi. A National Representative Study.

ME Loeb, Arne H Eide SINTEF Health Research (2004) C1

This research report provides results from the study on living conditions among people with disabilities in Malawi. Comparisons are made between individuals with and without disabilities and also between households with and without a disabled family member. Results obtained in Malawi are also comp... more

Download (644)

View PDF (2780)

2015 Pipeline Report HIV, Hepatitis C virus (HCV), and Tuberculosis (TB)

Polly Clayden, Simon Collins, Mike Frick, et al. A. Benzacar; HIV i-BASETREATMENT ACTION GROUP (2015)

Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development

Download (595)

View PDF (1218)

Effects of Response to 2014–2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa

Alyssa S. Parpia, Martial L. Ndeffo-Mbah, Natasha S. Wenzel, et al. (2016) C_CDC

Download (906)

View PDF (600)

Exclusión social en salud. Paraguay 2007. Análisis a nivel Nacional y Regional

Organización Panamericana de la Salud, Ministerio de la Salud Pública y Bienestar Social, et al. (2007) C1

Download (358)

View PDF (2213)

Recommendations of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the Diagnosis and Treatment of Non-tuberculous Mycobacterioses

N. Schoenfeld, W. Haas, E. Richter, et al. (2016) C2

Empfehlungen zur Diagnostik und Therapie nichttuberkulöser Mykobakteriosen des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP). Schönfeld N et al. Recommendations of the German Central Committee… Pneumolo... more

Download (279)

View PDF (1133)

Coordinated public health surveillance between points of entry and national health surveillance systems

World Health Organization (2014)

Advising principles. The purpose of this document is to support competent authorities in charge of IHR implementation to improve national capacities for the prevention, detection and control of events, by strengthening communications and coordination between points of entry and the national health s... more

Download (179)

View PDF (335)

Roadmap to prevent and combat drug-resistant tuberculosis

World Health Organization Europe (2011) C_WHO

Download (478)

View PDF (830)

Peraturan Menteri Kesehatan Republik Indonesia Nomor 13 Tahun 2013 Tentang Pedoman Manajemen Terpadu Pengendalian Tuberkulosis Resistan Obat

Kementerian Kesehatan Republik Indonesia (2013) C1

Download (226)

View PDF (392)

Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis

World Health Organization (2017) C_WHO

Download (256)

View PDF (421)

Report of the Guideline Development Group Meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis

World Health Organization (2017) C_WHO

A review of available evidence (2016). 28-29 June 2016; Geneva, Switzerland The END TB strategy.

Download (177)

View PDF (298)

Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System. (Russian Version)

World Health Organization (2011) C_WHO

Автоматизированная технология амплификации нуклеиновых кислот в режиме реального времени для быстрого и одновременного выявления туберкулеза и устойчивости к р... more

Download (92)

View PDF (102)

Mitigating the impact of COVID-19 on countries affected by HIV, tuberculosis and malaria

Global fund (2020) CC

While many of the countries hit by the COVID-19 in the first few months of the year are now beginning to relax lockdown measures as infection and death rates fall, in the regions most affected by HIV, TB and malaria, such as Africa, South Asia and Latin America, the pandemic continues to accelerate.... more

Download (364)

View PDF (372)

Framework and toolkit for infection prevention and control in outbreak preparedness, readiness and response at the national level

World Health Organization WHO (2021) C_WHO

14 Dec 2021

Download (67)

View PDF (1141)

The effect of primary health care on tuberculosis in a nationwide cohort of 7·3 million Brazilian people: a quasi-experimental study

Jesus, G.S.; J.M. Pescarini, A.F.Silva, et al. (2022) CC

The Lancet Global Health January 24, 2022

Download (90)

View PDF (145)

New data shows COVID-19 combined with funding shortfalls are devastating efforts to end Tuberculosis (TB) by 2030

Stop TB Partnership; WHO (2021) C_WHO

28 September 2021 Less than half of required funding has been provided globally with dramatic consequences as hundreds of thousands more die from TB

Download (128)

View PDF (164)

Third progress analysis of implementation of antimicrobial resistance national action plans in the WHO South-East Asia Region

World Health Organization WHO (2022) C_WHO

Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder or impossible to treat, and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has... more

Download (191)

View PDF (178)

Guidance to facilitate monitoring and evaluation for antimicrobial resistance national action plans

Quadripartite: Food and Agriculture Organization of the United Nations FAO; UN Environment Programme UNEP; World Health Organization WHO; World Organisation for Animal Health WAHO (2023) CC

Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...socioeconomic development. Just like the climate crisis, AMR poses a significant threat to the delivery of the 2030 Agenda for Sustainable Development. The response to the AMR crisis has been spearheaded through the global action plan on antimicrobial resistance (GAP-AMR), developed by the World Health Organization (WHO) in 2015, in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (WOAH), and formally endorsed by the three organizations’ governing bodies and by the Political Declaration of the high-level meeting of the United Nations General Assembly on AMR in 2016. In 2022, the three organizations officially became the Quadripartite by welcoming the United Nations Environment Programme (UNEP) into the alliance “to accelerate coordination strategy on human, animal and ecosystem health”. The aim of the GAP-AMR is to ensure the continuity of successful treatment with effective and safe medicines. Its strategic objectives include: • improving the awareness and understanding of AMR; • strengthening the knowledge and evidence base through surveillance and research; • reducing the incidence of infection through effective sanitation, hygiene and infection prevention measures; optimizing the use of antimicrobial medicines in human and animal health; and • developing the economic case for sustainable investment that takes account of the needs of all countries and increasing investment in new medicines, diagnostic tools, vaccines and other interventions. With the adoption of the GAP-AMR, countries agreed to develop national action plans (NAPs) aligned with the GAP-AMR to mainstream AMR interventions nationally. Individually, the Quadripartite took action to advance AMR interventions in their respective sectors. FAO adopted a resolution on AMR recognizing that it poses an increasingly serious threat to public health and sustainable food production, and developed an AMR action plan to support the resolution’s implementation. For its part, WOAH developed a strategy on AMR aligned with the GAP-AMR, acknowledging the importance of a One Health approach to AMR. Similarly, more recently, UNEP’s governing body, the United Nations Environment Assembly, recognized that AMR is a current and increasing threat and a challenge to global health, food security and the sustainable development of all countries, and welcomed the GAP-AMR and the NAPs developed in accordance with its five overarching strategic objectives more